RP Management’s Immunomedics Inc IMMU Stock Holding History

RP Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,373,178	Closed	-$372M	–	6
2020 Q3	$372M	Hold	4,373,178	–	–	55.73%	1
2020 Q2	$155M	Hold	4,373,178	–	–	29.96%	1
2020 Q1	$59M	Hold	4,373,178	–	–	18.3%	3
2019 Q4	$92.5M	Hold	4,373,178	–	–	20.92%	3
2019 Q3	$58M	Hold	4,373,178	–	–	37.14%	2
2019 Q2	$60.7M	Hold	4,373,178	–	–	37.2%	2
2019 Q1	$84M	Hold	4,373,178	–	–	42.02%	2
2018 Q4	$62.4M	Buy	+4,373,178	New	+$86.8M	42.73%	2

RP Management's IMMU Position: Q4 2020 in Review

RP Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 4,373,178 shares — an estimated $372M sold.

RP Management first reported a position in IMMU in Q4 2018 and held it in 8 quarters. The position peaked at $372M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

RP Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
RP Management sold 4,373,178 Immunomedics Inc shares in Q4 2020, an estimated $372M.
RP Management first reported a position in Immunomedics Inc in Q4 2018 and held it in 8 quarters.
RP Management's Immunomedics Inc position peaked at $372M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on RP Management's 13F filing for Q4 2020, filed 16 Feb 2021.